undamentalytics Newsletter
Sign in

Insmed Inc income statement

In fiscal 2025, Insmed Inc reported revenue of $606m, up 66.7% on the year before, operating income of −$1.25bn (a -205.6% margin) and net income of −$1.28bn, or −$6.42 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue1074012000101361641882453053646061,520
Cost of revenue——————002244044556686123237
Gross profit——————0071121251441902402784831,283
Research and development9529304474123110145132181273398571598771944
Selling, general and administrative————————————266345461701960
General and administrative1010121322435179168211204234—————
Operating income−9−8−62−42−55−117−173−189−307−235−265−375−457−710−878−1,247−564
Interest expense10012336252830402682858481
Income before tax119−6−60−41−57−120−176−193−324−254−293−436−480−747−910−1,272−598
Income tax0000−1−20−0011−213458
Net income118−6−60−41−56−118−176−193−324−254−294−435−482−750−914−1,277−606
Diluted EPS$9.30−$0.49−$2.95−$1.56−$1.60−$2.02−$2.85−$2.89−$4.22−$3.01−$3.01−$3.88−$3.91−$5.34−$5.57−$6.42−$2.80
Diluted shares (average)—13m23m27m35m59m62m67m77m85m98m112m123m140m164m199m216m
EBITDA−8−8−61−42−54−116−171−186−304−230−256−366−452−704−872−1,236−551

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HALO vs INSMALKS vs INSMINSM vs MDGL

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Insmed Inc's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Insmed Inc.